drugset / Trial / NCT06672133

Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC

NCT06672133

Phase 3 Not yet recruiting 524 enrolled Jinming Yu
RandomizedParallel-groupOpen-labelTreatment

Summary

This phase III trial compares the effect of adding radiation therapy to the usual maintenance therapy with adebrelimab versus adebrelimab alone in patients who have already received debrelimab plus chemotherapy for the treatment of extensive stage small cell lung cancer.

Timeline

Start
2024-12
Primary completion
2029-06
Completion
2029-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Adebrelimab Monoclonal antibody Intravenous